As the IGF2BP1-driven malignant phenotypes observed in clinical specimens may have resulted from intercellular interactions between IGF2BP1-expressing CRC cells and neighboring host cells within a tumor microenvironment (TME) or IGF2BP1-experssing CRC cells alone. Here, IGF2BP1 is linked to neoplasm.